Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Registers Shares for Selling Stockholders

NEW YORK (GenomeWeb News) – Helicos BioSciences has filed a prospectus with the US Securities and Exchange Commission on behalf of selling shareholders offering around 6.6 million shares of the firm's common stock.

The firm will offer the resale from time to time of up to 6,633,789 shares of its common stock, with 2,322,509 of those shares issuable upon exercise of warrants. Helicos is not selling any securities in the offering and will not receive any of the proceeds from the selling shareholders.

The total shares of common stock being offered, including the warrants, is the same number of shares that the firm recently issued in a private placement that netted Helicos $9.4 million in proceeds.

Among the investors in that private placement that are also listed in the prospectus as potential selling shareholders are Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures, and the firm's CEO, Ron Lowy. Also listed in the prospectus as potential sellers are other investors including Empery Asset Management, Capital Ventures International, Hudson Bay, RA Capital Healthcare Fund, and Ramius.

Helicos notes in the prospectus that the selling shareholders may "sell some, all or none of their shares."

In early Thursday trade on the Nasdaq, Helicos' shares were down 2 percent at $2.81.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.